SEC Reviews Novel ETFs, Including Prediction Markets and Leveraged Products
The U.S. Securities and Exchange Commission (SEC) is conducting a broad review of 'novel ETFs,' including leveraged funds and prediction-market products. The industry has pushed back against the SEC's expansive definition, arguing it could hinder innovation by slowing product launches. Over 20 firms submitted comments ahead of an August deadline, with major players like Charles Schwab, Franklin Templeton, Cboe Global Markets, Grayscale Investments, and YieldMax involved. The ETF market has grown significantly from $4 trillion in assets to over $12 trillion by the end of 2025. Products such as leveraged and inverse ETFs have become mainstream, with companies like Direxion and YieldMax expanding into complex strategies involving derivatives and options income funds. The SEC is also examining prediction-market ETFs that would track political events via platforms like Kalshi. Industry groups are urging the SEC to focus on risk-based regulation rather than labeling products as 'novel.' Regulators aim to balance innovation with investor protection, but issuers fear new approval hurdles could stifle established strategies. The outcome of this review may shape future ETF development and regulatory approaches.
Tickers: $BEN $CBOE $SCHW $SCHW PRD $YMAX
Topics: ETFs leveraged funds prediction markets SEC regulation